|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2024―Apr―22 |
COVID-19 Study: A New Principle Discovery |
Da-Yong Lu, Ting-Ren Lu |
2 |
[GO] |
2023―Aug―01 |
COVID-19 Research, Public Health, and Biomedical Basis |
Da Yong Lu, Ting Ren Lu |
3 |
[GO] |
2023―Jun―02 |
Ayush Kwath: a major contribution of Ayurveda in preventing COVID-19 infection |
Rohit Sharma, Priya Katoch, Kirti Raina, Rohit Sharma, Ashun Chaudhary |
4 |
[GO] |
2023―May―03 |
Natural product-derived phytochemicals as potential inhibitors of angiotensin converting enzyme 2 (ACE2): promising drug candidates for COVID-19 |
Aparna D. Palshetkar, Aarti. U. Rasal, Aruna Murugan, Namita D. Desai |
5 |
[GO] |
2023―Feb―28 |
Evaluation of the Effectiveness of Remdesivir in the Treatment of COVID-19 Outpatients: A retrospective cohort study |
Akram Asghari, Seyed Yaser Foroughi Ghomi, Abolfazl Mohammadbeigi, Abbas Ahmadi, Sajjad Ahmadpour, Mansoureh Shakeri, Seyed Hassan Adeli, Jamshid Vafaei Manesh, Reihane Tabaraii, Rasoul Shajari, Mostafa Vahedian |
6 |
[GO] |
2023―Feb―03 |
Safety Profile of Molnupiravir with Significant Effect on COVID-19: A Review |
Ashok Pattnaik, Tuhin Mukherjee, Payel Mal, Abhay Kumar Upadhyay, Satyajit Mohanty, Nikita Nayak, Ravi Pratap Singh, Tanisha Das, Sourav Basak |
7 |
[GO] |
2022―Apr―30 |
Overview of Drug Therapy of COVID-19 with Safety and the Potential Clinical Benefits |
Rajesh Basnet, Sandhya Khadka, Buddha Bahadur Basnet, Til Bahadur Basnet, Sanjeep Sapkota |
8 |
[GO] |
2021―Jul―20 |
Nanoantioxidant/Antioxidant therapy in 2019-nCoV: A new approach to reactive oxygen species mechanisms |
Ali Fathijouzdani, Rezvan Heidarimoghadam, Maryam Hazhirkamal, Akram Ranjbar |
9 |
[GO] |
2021―Jul―20 |
In silico approach to predict the SARS-CoV2 derived candidate miRNAs as potential antiviral therapy |
Soh Kavousi Pour, Shiva Mohammadi, Ebrahim Eftekhar, Sajad Jalili, Elham Arabizadeh, Pooneh Mokaram, Mahdi Barazesh, Seyed Hamid Moosavy |
10 |
[GO] |
2021―May―05 |
Comparison of clinical characteristics, laboratory findings and imaging manifestations of COVID-19 in sulfur mustard-exposed survivors and others: a case-control study |
Seyed Reza Hosseini Zijoud, Seyed Mohammad Javad Hosseini, Seyed Ali Mirhosseini, Jennifer Swann, Majid Mirzaei Nodoushan, Mojtaba Sharti, Hamidreza Ebrahimi Nezhad, Hassan Amanpour, Maryam Shahriari, Gholamreza Farnoosh, Mohsen Abbasi Farajzadeh, Alireza Jalali Farahani |
11 |
[GO] |
2020―Nov―13 |
Therapeutic agents for COVID-19: An Overview |
Sreejan Manna, Mainak Mal, Manas Bhowmik, Dipika Mandal |
12 |
[GO] |
2020―Aug―16 |
COVID-19: Pathogenesis and Pharmacological Basis for Use of Passive Antibody Therapy |
Smriti Ojha, Hina Chadha, Seema Mahor |
13 |
[GO] |
2020―Jul―20 |
CORONAVIRUS and COVID-19: A Systematic Review and perspective |
Harshal Ashok Pawar, Anjali Harshal Pawar, Sandip Ashok Pawar, Prashant Ashok Pawar |